Rock Springs Capital Management LP Q4 2018 Filing
Filed February 14, 2019
Portfolio Value
$2.1B
Holdings
133
Report Date
Q4 2018
Filing Type
13F-HR
All Holdings (133 positions)
| Stock | Value |
|---|---|
UNHUNITEDHEALTH GROUP INC | $150.2M |
WCGEURWELLCARE HEALTH PLANS INC | $92.0M |
ISRGINTUITIVE SURGICAL INC | $72.8M |
AMRNAMARIN CORP PLC | $60.9M |
—GW PHARMACEUTICALS PLC | $58.4M |
HCAHCA HEALTHCARE INC | $56.6M |
NBIXNEUROCRINE BIOSCIENCES INC | $56.3M |
PCRXPACIRA PHARMACEUTICALS INC | $53.8M |
EHCENCOMPASS HEALTH CORP | $44.7M |
—TESARO INC | $44.7M |
MOHMOLINA HEALTHCARE INC | $39.7M |
SRPTSAREPTA THERAPEUTICS INC | $35.7M |
—LOXO ONCOLOGY INC | $33.8M |
VRTXVERTEX PHARMACEUTICALS INC | $33.6M |
TFXTELEFLEX INC | $33.6M |
IRTCIRHYTHM TECHNOLOGIES INC | $33.5M |
BSXBOSTON SCIENTIFIC CORP | $32.3M |
ONCBEIGENE LTD | $30.1M |
EWEDWARDS LIFESCIENCES CORP | $28.1M |
SYKSTRYKER CORP | $28.1M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $27.6M |
PENPENUMBRA INC | $27.5M |
—WRIGHT MED GROUP N V | $27.2M |
MDGLMADRIGAL PHARMACEUTICALS INC | $27.2M |
EXASEXACT SCIENCES CORP | $24.3M |
ALXNALEXION PHARMACEUTICALS INC | $23.6M |
ACHCACADIA HEALTHCARE COMPANY IN | $23.2M |
AFWALIGN TECHNOLOGY INC | $22.0M |
TMOTHERMO FISHER SCIENTIFIC INC | $21.5M |
ALLKGUSDALLAKOS INC | $21.1M |
—SPARK THERAPEUTICS INC | $21.0M |
IDXXIDEXX LABS INC | $20.6M |
BAXBAXTER INTL INC | $19.8M |
INCYINCYTE CORP | $19.7M |
RAREULTRAGENYX PHARMACEUTICAL IN | $18.5M |
PRAHPRA HEALTH SCIENCES INC | $18.4M |
—RADIUS HEALTH INC | $18.1M |
ARGXARGENX SE | $17.1M |
GLPGGALAPAGOS NV | $16.3M |
WSTWEST PHARMACEUTICAL SVSC INC | $15.7M |
NVTA1EURINVITAE CORP | $15.5M |
ASNDASCENDIS PHARMA A S | $15.3M |
—ALDER BIOPHARMACEUTICALS INC | $15.1M |
BIIBBIOGEN INC | $15.0M |
INGNINOGEN INC | $14.5M |
—OBSEVA SA | $14.2M |
FGENEURFIBROGEN INC | $14.2M |
ALNYALNYLAM PHARMACEUTICALS INC | $14.1M |
TBPHTHERAVANCE BIOPHARMA INC | $14.1M |
—MEDICINES CO | $13.9M |
—RA PHARMACEUTICALS INC | $13.7M |
HRTXHERON THERAPEUTICS INC | $13.6M |
—INTERSECT ENT INC | $13.1M |
AXGNAXOGEN INC | $12.3M |
AG8AGILENT TECHNOLOGIES INC | $12.3M |
EX9EXELIXIS INC | $12.2M |
ZBHZIMMER BIOMET HLDGS INC | $12.2M |
CELGCELGENE CORP | $11.9M |
2L9BLUEPRINT MEDICINES CORP | $11.5M |
SGENEURSEATTLE GENETICS INC | $11.5M |
IM8NINSMED INC | $11.2M |
—IMMUNOMEDICS INC | $11.1M |
DVADAVITA INC | $11.1M |
BMRNBIOMARIN PHARMACEUTICAL INC | $11.0M |
—AUDENTES THERAPEUTICS INC | $10.7M |
ASMBASSEMBLY BIOSCIENCES INC | $10.2M |
FIXXEURHOMOLOGY MEDICINES INC | $10.1M |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $10.1M |
—EPIZYME INC | $9.9M |
ACRSACLARIS THERAPEUTICS INC | $9.8M |
RIGLUSDRIGEL PHARMACEUTICALS INC | $9.7M |
—BIOHAVEN PHARMACTL HLDG CO L | $9.6M |
AM6AMICUS THERAPEUTICS INC | $9.6M |
PBYIPUMA BIOTECHNOLOGY INC | $9.3M |
—RETROPHIN INC | $9.1M |
ANABANAPTYSBIO INC | $8.7M |
—ZOGENIX INC | $8.6M |
ZLABZAI LAB LTD | $8.1M |
GHGUARDANT HEALTH INC | $8.1M |
IFRXINFLARX NV | $7.9M |
—TRANSLATE BIO INC | $7.6M |
FRPTFRESHPET INC | $7.6M |
—RTI SURGICAL INC | $7.2M |
NVCRNOVOCURE LTD | $6.5M |
MRTXEURMIRATI THERAPEUTICS INC | $6.4M |
—ODONATE THERAPEUTICS INC | $6.3M |
CHRSCOHERUS BIOSCIENCES INC | $6.1M |
AXNX*AXONICS MODULATION TECH INC | $6.0M |
NVAXNOVAVAX INC | $6.0M |
—GLOBAL CORD BLOOD CORPORATIO | $6.0M |
—PORTOLA PHARMACEUTICALS INC | $5.9M |
RYTMRHYTHM PHARMACEUTICALS INC | $5.8M |
—MYOVANT SCIENCES LTD | $5.7M |
BCRXBIOCRYST PHARMACEUTICALS | $5.6M |
—APTINYX INC | $5.0M |
AGLEUSDAEGLEA BIOTHERAPEUTICS INC | $4.9M |
CBAYUSDCYMABAY THERAPEUTICS INC | $4.8M |
—FIVE PRIME THERAPEUTICS INC | $4.7M |
SG7SAGE THERAPEUTICS INC | $4.7M |
CLVSEURCLOVIS ONCOLOGY INC | $4.6M |
Page 1 of 2Next